Enzon Pharmaceuticals, Inc.
USD4.99
-0.12 (-2.35%)
CEO
Richard L. Feinstein
IPO Date
1984-02-15
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$5.37
Prev. Close
$5.11
Day Low
$4.88
Day High
$5.37
52W Low
$0.02
52W High
$8.55
Market Cap
$0.00B
Volume
0.00M
| 14.9 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | 0.2% | 0.2% | 0.00 | 27.62 | 70.8 |
| 31 Dec 2022 | FY | 100.0% | -715.4% | -0.4% | -0.4% | 0.00 | 27.89 | -98.4 |
| 31 Dec 2021 | FY | 100.0% | -66.9% | -1.0% | -1.0% | 0.00 | 118.50 | -54.2 |
| 31 Dec 2020 | FY | 100.0% | -2521.2% | -2.7% | -2.7% | 0.00 | 117.07 | -9.7 |
| 31 Dec 2019 | FY | 100.0% | -472.9% | -16.2% | -15.1% | 0.00 | 14.17 | -9.3 |
| 31 Dec 2018 | FY | 100.0% | 84.5% | 39.0% | 37.7% | 0.00 | 28.12 | 1.9 |
| 31 Dec 2017 | FY | 100.0% | 65.0% | 59.5% | 57.2% | 0.00 | 20.58 | 2.2 |
| 31 Dec 2016 | FY | 100.0% | -13.4% | -10.9% | -10.0% | 0.00 | 8.41 | -12.2 |
| -0.7 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -1.9% | -1.9% | 0.00 | 80.86 | -1.8 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -229.2% | -2.2% | 0.00 | 55.71 | -2.4 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -26.8% | -1.2% | 0.00 | 82.17 | -3.6 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -2.4% | -0.2% | 0.00 | 28.10 | -40.2 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | 9.2% | 0.5% | 0.00 | 107.24 | 10.2 |
| 30 Jun 2024 | Q2 | 100.0% | 1061.5% | 0.6% | 0.6% | 0.00 | 113.75 | 11.4 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | 0.7% | 0.7% | 0.00 | 89.19 | 4.5 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | 1.5% | 1.4% | 0.00 | 27.62 | 2.6 |